Storage
2-8°C in dark, sealed, dry place, no frozen.
Detection Limit
0.25 ng/mL
General Description
Carbamazepine is widely used for the treatment of epilepsy, affective disorders, trigeminal neuralgia, and other conditions. Carbamazepine stabilizes the inactivation state of sodium channels both in the central nervous system and in the heart, thereby reducing depolarization and decreasing glutamate release. This may explain the neurological and cardiac effects observed in overdose situations. Measurement of carbamazepine concentration may have important implications for patient management. Carbamazepine concentrations above 40 mcg/ml are considered to be associated with the risk for severe clinical manifestations such as depressed consciousness, respiratory depression, cardiac conduction disorders, seizures, and death (1, 2).
Citations
Have you cited DTS-NS007 in a publication?
Let us know and earn a reward for your research.
| Product Name |
Cat. No. |
Applications |
Host Species |
Datasheet |
Price |
Add to Basket |
| Product Name |
Cat. No. |
Applications |
Host Species |
Datasheet |
Price |
Add to Basket |
Parant, F; Bossu, H; et al. Cross-reactivity assessment of carbamazepine-10,11-epoxide, oxcarbazepine, and 10-hydroxy-carbazepine in two automated carbamazepine immunoassays: PETINIA and EMIT 2000. THERAPEUTIC DRUG MONITORING 25:41-45(2003).
Ingafou, M; Lodi, G; et al. Oral lichen planus is not associated with IgG circulating antibodies to epithelial antigens. ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS 84:175-178(1997).